Current and historical daily PE Ratio for Homology Medicines Inc (
) from 2018 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Homology Medicines stock (LTS:0T6G) PE ratio as of Jun 08 2024 is 0.
More Details
Homology Medicines Inc (LTS:0T6G) PE Ratio (TTM) Chart
Homology Medicines Inc (LTS:0T6G) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1238
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Homology Medicines PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
| 2024-03-21 | At Loss | 2024-01-18 | At Loss |
| 2024-03-20 | At Loss | 2024-01-17 | At Loss |
| 2024-03-19 | At Loss | 2024-01-16 | At Loss |
| 2024-03-18 | At Loss | 2024-01-15 | At Loss |
| 2024-03-15 | At Loss | 2024-01-12 | At Loss |
| 2024-03-14 | At Loss | 2024-01-11 | At Loss |
| 2024-03-13 | At Loss | 2024-01-10 | At Loss |
| 2024-03-12 | At Loss | 2024-01-09 | At Loss |
| 2024-03-11 | At Loss | 2024-01-08 | At Loss |
| 2024-03-08 | At Loss | 2024-01-05 | At Loss |
| 2024-03-07 | At Loss | 2024-01-04 | At Loss |
| 2024-03-06 | At Loss | 2024-01-03 | At Loss |
| 2024-03-05 | At Loss | 2024-01-02 | At Loss |
| 2024-03-04 | At Loss | 2024-01-01 | At Loss |
| 2024-03-01 | At Loss | 2023-12-29 | At Loss |
| 2024-02-29 | At Loss | 2023-12-28 | At Loss |
| 2024-02-28 | At Loss | 2023-12-27 | At Loss |
| 2024-02-27 | At Loss | 2023-12-26 | At Loss |
| 2024-02-26 | At Loss | 2023-12-25 | At Loss |
| 2024-02-23 | At Loss | 2023-12-22 | At Loss |
| 2024-02-22 | At Loss | 2023-12-21 | At Loss |
| 2024-02-21 | At Loss | 2023-12-20 | At Loss |
| 2024-02-20 | At Loss | 2023-12-19 | At Loss |
| 2024-02-19 | At Loss | 2023-12-18 | At Loss |
| 2024-02-16 | At Loss | 2023-12-15 | At Loss |
| 2024-02-15 | At Loss | 2023-12-14 | At Loss |
| 2024-02-14 | At Loss | 2023-12-13 | At Loss |
| 2024-02-13 | At Loss | 2023-12-12 | At Loss |
| 2024-02-12 | At Loss | 2023-12-11 | At Loss |
| 2024-02-09 | At Loss | 2023-12-08 | At Loss |
| 2024-02-08 | At Loss | 2023-12-07 | At Loss |
| 2024-02-07 | At Loss | 2023-12-06 | At Loss |
| 2024-02-06 | At Loss | 2023-12-05 | At Loss |
| 2024-02-05 | At Loss | 2023-12-04 | At Loss |
| 2024-02-02 | At Loss | 2023-12-01 | At Loss |
| 2024-02-01 | At Loss | 2023-11-30 | At Loss |
| 2024-01-31 | At Loss | 2023-11-29 | At Loss |
| 2024-01-30 | At Loss | 2023-11-28 | At Loss |
| 2024-01-29 | At Loss | 2023-11-27 | At Loss |
| 2024-01-26 | At Loss | 2023-11-24 | At Loss |
| 2024-01-25 | At Loss | 2023-11-23 | At Loss |
| 2024-01-24 | At Loss | 2023-11-22 | At Loss |
Homology Medicines Inc (LTS:0T6G) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Homology Medicines Inc
NAICS : 325412
SIC : 2834
ISIN : US4380831077
Description
Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers